P605: T-CELL PROLYMPHOCYTIC LEUKEMIA: MOLECULAR CHARACTERIZATION OF A COHORT OF 18 PATIENTS AND EVALUATION OF BORTEZOMIB AS A POSSIBLE THERAPEUTIC STRATEGY. (23rd June 2022) - Gasparini, V. R.; Martines, A.; Barilà, G.; Teramo, A.; Calabretto, G.; Vicenzetto, C.; Carraro, S.; Trimarco, V.; Trentin, L.; Facco, M.; Semenzato, G.; Bonaldi, L.; et al.